- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01350505
Toileting at Night in Older Adults: Light to Maximize Balance, Minimize Insomnia
September 26, 2018 updated by: VA Office of Research and Development
Toileting at Night in Older Adults: Light to Maximize Vision, Minimize Insomnia
To examine the change in balance that occurs in older individuals when exposed to different colored lights at night.
Study Overview
Status
Completed
Study Type
Interventional
Enrollment (Actual)
21
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
Palo Alto, California, United States, 94304-1290
- VA Palo Alto Health Care System, Palo Alto, CA
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
55 years to 85 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Aged 55-85
- Stable health
- Normal color vision
Exclusion Criteria:
- Alcohol abuse
- Depression
- Sleep disorders
- Smoking
- Use of illegal drugs
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: All subjects
13 minutes of light at night (2 hours after bedtime)
|
~200 lux of broad spectrum white light
~28 lux of broad spectrum white light
<0.5 lux of broad spectrum white light
~28 lux of orange light
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Balance
Time Frame: 13 minutes
|
Balance was assessed during a 13-minute nocturnal light exposure (4 different conditions) and differences between the conditions were assessed.
To determine goodness of balance while walking, the variability in stride length (i.e., variance in stride-to-stride length) was calculated in each of the conditions.
Increased variability in stride length is associated with increased risk of falling.
|
13 minutes
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Jamie M Zeitzer, PhD, VA Palo Alto Health Care System, Palo Alto, CA
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 15, 2013
Primary Completion (Actual)
January 31, 2017
Study Completion (Actual)
June 30, 2017
Study Registration Dates
First Submitted
May 6, 2011
First Submitted That Met QC Criteria
May 6, 2011
First Posted (Estimate)
May 9, 2011
Study Record Updates
Last Update Posted (Actual)
February 15, 2019
Last Update Submitted That Met QC Criteria
September 26, 2018
Last Verified
September 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- E0773-P
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Yes
IPD Plan Description
All relevant summary data is presented in a publication under review.
Anonymized, individual participant data would be made available upon request and completion of necessary documentation.
IPD Sharing Supporting Information Type
- Study Protocol
- Statistical Analysis Plan (SAP)
- Informed Consent Form (ICF)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Insomnia
-
Leiden UniversityBioClock Consortium; Caring UniveristiesCompleted
-
National Science Council, TaiwanCompleted
-
Sunshine Lake Pharma Co., Ltd.Unknown
-
Pfizer's Upjohn has merged with Mylan to form Viatris...Completed
-
Massachusetts General HospitalNational Institutes of Health (NIH)Completed
-
IpsenCompletedThe Effectiveness of Circadin in Improving Quality of Sleep in Patients Aged 55 or Over (QUALISLEEP)InsomniaRussian Federation
-
Charite University, Berlin, GermanyCompleted
-
Roxane LaboratoriesCompleted
-
Butler HospitalSunovionCompleted
Clinical Trials on White light exposure
-
University of ArizonaActive, not recruiting
-
University of ArizonaRecruiting
-
University of WashingtonIcahn School of Medicine at Mount Sinai; University of North Texas Health Science...CompletedSleep | Traumatic Brain Injury | TBIUnited States
-
University of ArizonaU.S. Army Medical Research Acquisition ActivityRecruitingSuicidal Ideation | Regulation, EmotionUnited States
-
Selcuk UniversityCompletedPost Operative Pain | Anxiety, DentalTurkey
-
Icahn School of Medicine at Mount SinaiCompletedFatigue | Traumatic Brain InjuryUnited States
-
Chang Gung Memorial HospitalRecruitingDelirium | Circadian DysrhythmiaTaiwan
-
University of WyomingCompletedBinge Eating | Eating Disorder | Circadian DysregulationUnited States
-
Matthew Neal MDTerminatedPancreatic Neoplasms | Rectal NeoplasmsUnited States
-
University of BaselCompletedMuscle Strength | Endurance Performance | Reaction TimeSwitzerland